FMCT-pc3.

We are funding research to test the preclinical efficacy of a special formulation of mebendazole designed to make the active ingredient more bioavailable and increase the uptake within cancer cells. Mebendazole is a FDA approved medication that has a favorable safety profile.
Preclinical Studies
07/11/2025

Topics

Other Projects of Interest

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be

FMCT-ct1.

We are in the preliminary planning to fund a two-armed, phase 2 clinical trial testing the adjunctive efficacy of the

FMCT-pc2.

We are funding a study that aims to optimize an in vitro experimental assay that is capable of testing individual